Literature DB >> 9789890

Life-threatening situations in sarcoidosis.

D G James1.   

Abstract

Life-threatening situations in sarcoidosis are extremely rare. They may be due to failure of vital organs--lungs, heart, kidney, liver and brain--and usually due to irreversible fibrosis. Respiratory failure follows irreversible pulmonary fibrosis and the development of cor pulmonale. Cardiac sarcoidosis is more sinister for it may be silent, ill-recognised with sudden death or high morbidity. It needs sophisticated techniques to uncover this latent iceberg. Renal failure may be due to granulomatous interstitial nephritis and/or nephrocalcinosis. Hepatic failure is due to intrahepatic cholestasis, portal hypertension and bleeding oesophageal varices. Neurosarcoidosis carries a mortality of 10 per cent, over twice that of sarcoidosis overall. The treatment of each situation is discussed including organ transplantation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789890

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  6 in total

1.  Infliximab therapy for hepatic and intestinal sarcoidosis.

Authors:  Helen S Te; Lucas Campbell; Saima Chohan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

2.  A sarcoidosis patient with hand involvement and large pulmonary lymph nodes: results of 1-year treatment with methotrexate.

Authors:  Ebru Alemdaroğlu; Arzu Ertürk; Ayşe Gürler Eroğlu
Journal:  Clin Rheumatol       Date:  2010-06-26       Impact factor: 2.980

3.  Diagnosis and Treatment in Neurosarcoidosis.

Authors:  Gökçen Gözübatik-Çelik; Uğur Uygunoğlu; Derya Uludüz; Ersan Atahan; Benan Müsellim; Sabahattin Saip; Aksel Siva
Journal:  Noro Psikiyatr Ars       Date:  2015-03-01       Impact factor: 1.339

4.  A rare cause of severe lactic acidosis.

Authors:  Saad Saeed; Aditya Kuravi; Matt Rowley; Marwa Saeed
Journal:  BMJ Case Rep       Date:  2015-04-24

Review 5.  Hypothalamic-pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review.

Authors:  Jeremy Anthony; Gregory J Esper; Adriana Ioachimescu
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

6.  FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET.

Authors:  Patrick Martineau; Matthieu Pelletier-Galarneau; Daniel Juneau; Eugene Leung; Pablo Nery; Rob deKemp; Rob Beanlands; David Birnie
Journal:  EJNMMI Res       Date:  2020-12-10       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.